Skip links

Deflazacort

Full Name deflazacort
Drug deflazacort
Manufacturer Upsher-Smith (tablets) and Cranbury (oral suspension)
Route of Administration Oral
Site of Care Home
Approved Indication Treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology
Enrollment Form Link Tablets Enrollment Form
Oral suspension Enrollment Form
Phone Number 800-605-1524
Fax Number 877-765-6254
Patient Resources Alex Rezcalla Foundation, Jett Foundation, and Parent Project Muscular Dystrophy